CGIM
IRWD icon

Cannon Global Investment Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Cannon Global Investment Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-44,000
Closed -$575K – 51
2021
Q3 		$575K Buy
+44,000
New +$569K 0.86% 29
2021
Q2 		– Sell
-32,000
Closed -$358K – 78
2021
Q1 		$358K Buy
+32,000
New +$338K 0.61% 58

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Cannon Global Investment Management's IRWD Position: Q4 2021 in Review

Cannon Global Investment Management sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2021, closing a stake of 44,000 shares — an estimated $575K sold.

Cannon Global Investment Management first reported a position in IRWD in Q1 2021 and held it in 2 quarters. The position peaked at $575K in Q3 2021. 212 funds tracked by Wall St. Rank hold IRWD as of Q4 2021.

  • Cannon Global Investment Management reported no remaining Ironwood Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Cannon Global Investment Management sold 44,000 Ironwood Pharmaceuticals shares in Q4 2021, an estimated $575K.
  • Cannon Global Investment Management first reported a position in Ironwood Pharmaceuticals in Q1 2021 and held it in 2 quarters.
  • Cannon Global Investment Management's Ironwood Pharmaceuticals position peaked at $575K in Q3 2021.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2021.

Based on Cannon Global Investment Management's 13F filing for Q4 2021, filed 4 Feb 2022.